TrialInvestigational new drugs2014

Pharmacokinetic/Pharmacodynamic modeling of abexinostat-induced thrombocytopenia across different patient populations: application for the determination of the maximum tolerated doses in both lymphoma and solid tumour patients.

Quentin Chalret du Rieu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.